4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]pyridine-2-carboxylic acid
CAS: 1012058-78-4
Ref. 3D-FC59377
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire |
Product Information
Regorafenib is a multikinase inhibitor that belongs to the group of targeted therapies. It has been shown to be effective in the treatment of advanced hepatocellular carcinoma and pancreatic cancer. Regorafenib inhibits all three cytochrome P450s (CYP1A2, CYP2C8, and CYP3A4) and can also inhibit other drug metabolizing enzymes such as UGT1A1. Regorafenib is not active against bacteria or fungi, but it has been shown to have anti-inflammatory properties in vitro.
Chemical properties
Technical inquiry about: 3D-FC59377 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]pyridine-2-carboxylic acid
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.